Agarwal Arjun 4
4 · Oruka Therapeutics, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Agarwal Arjun
SVP, Finance
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-22+120,000→ 120,000 totalExercise: $12.50Exp: 2035-01-21→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/48 of the underlying shares monthly from January 1, 2025.